2,3-dihydroxy-3-methylbutanoic acid
CAS No. 1756-18-9
2,3-dihydroxy-3-methylbutanoic acid( —— )
Catalog No. M28415 CAS No. 1756-18-9
2,3-dihydroxy-3-methylbutanoic acid is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 92 | In Stock |
|
| 2MG | 79 | In Stock |
|
| 5MG | 122 | In Stock |
|
| 10MG | 182 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 457 | In Stock |
|
| 100MG | 666 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1376 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2,3-dihydroxy-3-methylbutanoic acid
-
NoteResearch use only, not for human use.
-
Brief Description2,3-dihydroxy-3-methylbutanoic acid is a chemical compound.
-
Description2,3-dihydroxy-3-methylbutanoic acid is a chemical compound.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorleukotriene receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1756-18-9
-
Formula Weight134.131
-
Molecular FormulaC5H10O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(O)C(O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mancini JA, Prasit P, Coppolino MG, Charleson P, Leger S, Evans JF, Gillard JW, Vickers PJ. 5-Lipoxygenase-activating protein is the target of a novel hybrid of two classes of leukotriene biosynthesis inhibitors. Mol Pharmacol. 1992 Feb;41(2):267-72. PubMed PMID: 1538707.
molnova catalog
related products
-
Compound 35
Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses.Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses. Compounds 35 have shown good metabolic stability in plasma and liver microsomes (rat and human), and 32 did not inhibit CYP3A4 nor CYP2C9.
-
β-Amyloid (1-14) , m...
β-Amyloid (1-14) , mouse, rat
-
Metyrapone
Metyrapone is an inhibitor of cytochrome P450-mediated ω/ω-1 hydroxylase activity and CYP11B1.
Cart
sales@molnova.com